APA (7th ed.) Citation

R, S., J, H., M, I., P, A., JM, d. B., PM, C., . . . D, R. (2026). Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia. The New England journal of medicine. https://doi.org/10.1056/NEJMoa2604565

Chicago Style (17th ed.) Citation

R, Savarirayan, et al. "Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia." The New England Journal of Medicine 2026. https://doi.org/10.1056/NEJMoa2604565.

MLA (9th ed.) Citation

R, Savarirayan, et al. "Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia." The New England Journal of Medicine, 2026, https://doi.org/10.1056/NEJMoa2604565.